ATB Therapeutics raised €54M in a Series A funding led by EQT Life Sciences to enhance the ATBioFarm platform and accelerate development of weaponized antibodies for oncology.
Amount Raised
€54 Million
Round Type
Series A
AyeBiotechnologyTherapeuticsInvestors
Description
ATB Therapeutics, based in Aye, Belgium, has raised €54M in Series A funding. The funds will be used to expand their ATBioFarm platform and advance the development of innovative therapeutics for cancer treatment.
Quick answer
ATB Therapeutics raised €54 Million in a Series A round, dated November 18, 2024. Investors: Wallonie Entreprendre, Sfpim, EQT Life Sciences, MRL Ventures Fund, V Bio, Vives Partners and Sambrinvest. ATB Therapeutics is based in Aye, Wallonie, Belgium.
- How much did ATB Therapeutics raise?
- ATB Therapeutics raised €54 Million in a Series A round on November 18, 2024.
- Who invested in ATB Therapeutics?
- Wallonie Entreprendre, Sfpim, EQT Life Sciences, MRL Ventures Fund, V Bio, Vives Partners and Sambrinvest are named as investors in this round.
- What does ATB Therapeutics do?
- ATB Therapeutics is a Belgium-based company developing a therapeutic antibody pipeline driven by its proprietary ATBioFarm platform.
- Where is ATB Therapeutics based and how big is it?
- ATB Therapeutics is based in Aye, Wallonie, Belgium.
- Who are the decision-makers at ATB Therapeutics?
- Fundz holds 1 contact at ATB Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as ATB Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Os Therapies raised $6M (Post-IPO Equity) on December 31, 2024.
- Hinge Bio raised $31M on December 31, 2024.
- Os Therapies raised $7.1M on December 31, 2024.
- AusperBio raised $73M (Series B) on December 27, 2024.
- PolyPid raised $15M on December 26, 2024.
- Phio Pharmaceuticals raised $30K (Seed) on December 24, 2024.
Who to call at ATB Therapeutics, and when
A new round usually means ATB Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ATB Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ATB Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ATB Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ATB Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansATB Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.